{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:48Z","timestamp":1792787268958,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Center for Neurorestoration and Neurotechnology","award":["N2864-C"],"award-info":[{"award-number":["N2864-C"]}]},{"DOI":"10.13039\/100006380","name":"RR&D","doi-asserted-by":"crossref","award":["5I21RX003338"],"award-info":[{"award-number":["5I21RX003338"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,1,9]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Substance use disorders (SUDs) take an enormous toll on US Veterans and civilians alike. Existing empirically supported interventions vary by substance and demonstrate only moderate efficacy. Non-invasive brain stimulation represents an innovative treatment for SUDs, yet aspects of traditional neurostimulation may hinder its implementation in SUD populations. Synchronised transcranial magnetic stimulation (sTMS) uses rotating rare earth magnets to deliver low-field stimulation synchronised to an individual\u2019s alpha peak frequency that is safe for at-home administration. The current trial aims to assess the acceptability and feasibility of sTMS, as well as the safety of at-home sTMS administration for substance-disordered Veterans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Sixty Veterans in substance treatment at the Providence Veterans Affairs will be randomised to receive 6\u2009weeks of active or sham sTMS treatment. Eligibility will be confirmed by meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for an alcohol, cocaine or opioid use disorder. Daily supervised sTMS treatment will occur either in clinic or at home through video monitoring. Clinical and self-report assessments will be completed at baseline, end of treatment and 1-month follow-up. Urine drug screening will occur once per week during the treatment phase. Primary outcomes include treatment adherence\/retention and satisfaction to evaluate sTMS feasibility and acceptability in Veterans with SUDs. The safety of at-home sTMS administration will be assessed via adverse event monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The sTMS device received a significant risk determination for at-home use by the Food and Drug Administration in July 2021. Ethics approval was obtained in August 2021 from the Providence Veterans Affairs institutional review board and research and development committee. Data collection began in September 2021 and is planned to continue through December 2023. Findings will be disseminated at national conferences and in peer-reviewed journals. Results will serve to inform the development of large-scale clinical trials of sTMS efficacy for substance-disordered Veterans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04336293\">NCT04336293<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-066175","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T12:07:58Z","timestamp":1675080478000},"page":"e066175","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct04336293","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jonathan","family":"Jampel","sequence":"first","affiliation":[{"name":"Department of Psychology, Clark University, Worcester, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-5349","authenticated-orcid":false,"given":"McKenzie J","family":"Quinn","sequence":"additional","affiliation":[{"name":"Providence VA Medical Center, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L","family":"Catalano","sequence":"additional","affiliation":[{"name":"Therapeutic Sciences Graduate Program, Division of Biology and Medicine, Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsie B","family":"Benca-Bachman","sequence":"additional","affiliation":[{"name":"Providence VA Medical Center, Providence, Rhode Island, USA"},{"name":"Behavioral Genetics of Addition Laboratory, Department of Psychology, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Brick","sequence":"additional","affiliation":[{"name":"Providence VA Medical Center, Providence, Rhode Island, USA"},{"name":"Department of Psychiatry and Human Behavior, Quantitative Sciences Program, Alpert Medical School of Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah S","family":"Philip","sequence":"additional","affiliation":[{"name":"The Center of Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Swift","sequence":"additional","affiliation":[{"name":"The Center of Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA"},{"name":"Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"McGeary","sequence":"additional","affiliation":[{"name":"The Center of Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA"},{"name":"Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"2025101811372701000_13.1.e066175.1","doi-asserted-by":"publisher","DOI":"10.2147\/sar.s116720"},{"key":"2025101811372701000_13.1.e066175.2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.62.4.389"},{"key":"2025101811372701000_13.1.e066175.3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111851"},{"key":"2025101811372701000_13.1.e066175.4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300235"},{"key":"2025101811372701000_13.1.e066175.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04054.x"},{"key":"2025101811372701000_13.1.e066175.6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/15622975.2011.598383","article-title":"Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence","volume":"12 Suppl 1","author":"H\u00f6ppner","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"2025101811372701000_13.1.e066175.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.07.021"},{"key":"2025101811372701000_13.1.e066175.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02777.x"},{"key":"2025101811372701000_13.1.e066175.9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40473-017-0135-4","article-title":"Developing repetitive transcranial magnetic stimulation (rTMS) as a treatment tool for cocaine use disorder: a series of six translational studies","volume":"4","author":"Hanlon","year":"2017","journal-title":"Curr Behav Neurosci Rep"},{"key":"2025101811372701000_13.1.e066175.10","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.biopsych.2016.02.006","article-title":"10-hz repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex reduces heroin cue craving in long-term addicts","volume":"80","author":"Shen","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2025101811372701000_13.1.e066175.11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1176\/appi.neuropsych.16080147","article-title":"Outcome of non-invasive brain stimulation in substance use disorders: a review of randomized sham-controlled clinical trials","volume":"29","author":"Trojak","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2025101811372701000_13.1.e066175.12","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16cs10905","article-title":"Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression","volume":"79","author":"McClintock","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"2025101811372701000_13.1.e066175.13","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145707007717"},{"key":"2025101811372701000_13.1.e066175.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.05.021"},{"key":"2025101811372701000_13.1.e066175.15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.brs.2015.05.005","article-title":"Efficacy and safety of low-field synchronized transcranial magnetic stimulation (stms) for treatment of major depression","volume":"8","author":"Leuchter","year":"2015","journal-title":"Brain Stimul"},{"key":"2025101811372701000_13.1.e066175.16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41398-018-0220-9","article-title":"Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex","volume":"8","author":"Hanlon","year":"2018","journal-title":"Transl Psychiatry"},{"key":"2025101811372701000_13.1.e066175.17","first-page":"599","article-title":"Transdiagnostic effects of ventromedial prefrontal cortex transcranial magnetic stimulation on cue reactivity","volume":"3","author":"Kearney-Ramos","year":"2018","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2025101811372701000_13.1.e066175.18","first-page":"211","article-title":"Neuroimaging mechanisms of therapeutic transcranial magnetic stimulation for major depressive disorder","volume":"3","author":"Philip","year":"2018","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2025101811372701000_13.1.e066175.19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/da.22862","article-title":"Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder","volume":"36","author":"Philip","year":"2019","journal-title":"Depress Anxiety"},{"key":"2025101811372701000_13.1.e066175.20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.brs.2019.06.010","article-title":"Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression","volume":"12","author":"Philip","year":"2019","journal-title":"Brain Stimul"},{"key":"2025101811372701000_13.1.e066175.21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/add.14793","article-title":"Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis","volume":"115","author":"Lappan","year":"2020","journal-title":"Addiction"},{"key":"2025101811372701000_13.1.e066175.22","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10060864"},{"key":"2025101811372701000_13.1.e066175.23","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/10826080802495237","article-title":"Substance user treatment dropout from client and clinician perspectives: a pilot study","volume":"44","author":"Palmer","year":"2009","journal-title":"Subst Use Misuse"},{"key":"2025101811372701000_13.1.e066175.24","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2014-0188"},{"key":"2025101811372701000_13.1.e066175.25","unstructured":"Sobell L , Sobell M , Buchan G . Timeline followback method (drugs, cigarettes, and marijuana). 1996."},{"key":"2025101811372701000_13.1.e066175.26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0009-8981(78)90102-X","article-title":"A new variant of methylmalonic acidemia-defective coenzyme-apoenzyme binding in cultured fibroblasts","volume":"85","author":"Morrow","year":"1978","journal-title":"Clin Chim Acta"},{"key":"2025101811372701000_13.1.e066175.27","unstructured":"Schneider W , Eschman A , Zuccolotto A . E-prime user\u2019s guide. 2002."},{"key":"2025101811372701000_13.1.e066175.28","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"2025101811372701000_13.1.e066175.29","doi-asserted-by":"crossref","unstructured":"Rybarczyk B . Social and occupational functioning assessment scale (SOFAS). In: Kreutzer JS , DeLuca J , Caplan B , eds. Encyclopedia of Clinical Neuropsychology. New York: New York, NY: Springer, 2011: 2313.","DOI":"10.1007\/978-0-387-79948-3_428"},{"key":"2025101811372701000_13.1.e066175.30","doi-asserted-by":"publisher","DOI":"10.1037\/pas0000486"},{"key":"2025101811372701000_13.1.e066175.31","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22059"},{"key":"2025101811372701000_13.1.e066175.32","doi-asserted-by":"publisher","DOI":"10.1177\/1073191104269954"},{"key":"2025101811372701000_13.1.e066175.33","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(86)90060-0"},{"key":"2025101811372701000_13.1.e066175.34","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700035558"},{"key":"2025101811372701000_13.1.e066175.35","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.54.6.1063"},{"key":"2025101811372701000_13.1.e066175.36","doi-asserted-by":"crossref","unstructured":"Spielberger C . Manual for the state-trait anxiety inventory (form Y1\u2013 Y2). 1983;Vol. IV","DOI":"10.1037\/t06496-000"},{"key":"2025101811372701000_13.1.e066175.37","doi-asserted-by":"publisher","DOI":"10.1037\/t49981-000"},{"key":"2025101811372701000_13.1.e066175.38","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"2025101811372701000_13.1.e066175.39","doi-asserted-by":"crossref","first-page":"20451253211049920","DOI":"10.1177\/20451253211049921","article-title":"Transcranial magnetic stimulation for post-traumatic stress disorder","volume":"11","author":"Petrosino","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025101811372701000_13.1.e066175.40","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol Bull"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-066175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:37:37Z","timestamp":1760812657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-066175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,30]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/bmjopen-2022-066175"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-066175","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}